المؤلفون: Aletaha, Daniel, Snedecor, Sonya J., Ektare, Varun, Xue, Mei, Bao, Yanjun, Garg, Vishvas

مصطلحات موضوعية: economic analysis, dose reduction, flare, biologics withdrawal

جغرافية الموضوع: UMW:14572

وصف الملف: text/html

العلاقة: vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-17016/128Test; urn:nbn:at:at-ubmuw:3-17016; https://resolver.obvsg.at/urn:nbn:at:at-ubmuw:3-17016Test; local:99145362170803331; system:AC15628201

الإتاحة: https://doi.org/10.2147/CEOR.S136327Test
https://resolver.obvsg.at/urn:nbn:at:at-ubmuw:3-17016Test

المؤلفون: Shivaji, Uday N, Bazarova, Alina, Critchlow, Tamsin, Smith, Samuel C L, Nardone, Olga Maria, Love, Melanie, Davis, Joanne, Ghosh, Subrata, Iacucci, Marietta

المساهمون: Shivaji, Uday N, Bazarova, Alina, Critchlow, Tamsin, Smith, Samuel C L, Nardone, Olga Maria, Love, Melanie, Davis, Joanne, Ghosh, Subrata, Iacucci, Marietta

مصطلحات موضوعية: Crohn’s disease, IBD, biologics discontinuation, biologics withdrawal, direct cost, health economic, predictors of prognosi, ulcerative colitis

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000603555800001; volume:13; firstpage:1756284820981216; journal:THERAPEUTIC ADVANCES IN GASTROENTEROLOGY; https://hdl.handle.net/11588/949418Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85098264244

الإتاحة: https://doi.org/10.1177/1756284820981216Test
https://hdl.handle.net/11588/949418Test

المؤلفون: Sonya J. Snedecor, Varun Ektare, Daniel Aletaha, Yanjun Bao, Mei Xue, Vishvas Garg

المصدر: ClinicoEconomics and Outcomes Research: CEOR

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Economics, Econometrics and Finance (miscellaneous), Tapering, economic analysis, Etanercept, 03 medical and health sciences, 0302 clinical medicine, Stable Disease, Internal medicine, medicine, Adalimumab, Economic analysis, flare, health care economics and organizations, Original Research, 030203 arthritis & rheumatology, business.industry, Health Policy, biologics withdrawal, medicine.disease, Infliximab, Surgery, ClinicoEconomics and Outcomes Research, 030104 developmental biology, dose reduction, Rheumatoid arthritis, Tumor necrosis factor alpha, business, medicine.drug

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2373662328a3abaa575e2724904e64a7Test
https://doi.org/10.2147/ceor.s136327Test

المؤلفون: Tamsin Critchlow, Melanie Love, Subrata Ghosh, Olga Maria Nardone, Uday N. Shivaji, Marietta Iacucci, Joanne Davis, Samuel C. Smith, Alina Bazarova

المصدر: Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology, Vol 13 (2020)

مصطلحات موضوعية: Crohn’s disease, medicine.medical_specialty, Crohn's disease, Health economics, business.industry, IBD, Gastroenterology, biologics withdrawal, Inflammatory Bowel Diseases, predictors of prognosis, medicine.disease, Ulcerative colitis, Discontinuation, biologics discontinuation, Clinical Practice, Indirect costs, health economics, Medicine, lcsh:Diseases of the digestive system. Gastroenterology, direct costs, lcsh:RC799-869, business, Intensive care medicine, Original Research, ulcerative colitis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc6d12bb902b6008230dd63bae5cff99Test
https://doi.org/10.1177/1756284820981216Test